The noninvasive mouse ear swelling assay. I. Refinements for detecting weak contact sensitizers.
The noninvasive mouse ear swelling assay (MESA) is a model for delayed-type hypersensitivity that holds promise as a testing protocol for allergic contact dermatitis (ACD). The MESA employs only topical sensitization on the abdomen and does not use injections, adjuvants, anesthesia, occlusion, or disruption of the stratum corneum. Five days after induction, the ears are challenged topically and ear swelling measurements taken at 24, 48, and 72 hr indicate the extent of ACD. In this study, refinements of the assay were explored in BALB/cBy mice using dinitrofluorobenzene (DNFB) and dinitrochlorobenzene (DNCB). A complete dose-response curve was developed for DNFB and the dose which sensitized half the mice in a group (SD50, 0.001%, w/v) was used to test noninvasive enhancement protocols. Several triple-dose protocols tested produced no increase in responsiveness and daily dosing showed a trend toward tolerance induction yielding 20% positive responses. Dietary vitamin A supplementation produced a dramatic enhancement of the responses: ear thickness increase was doubled and the SD50 sensitized 94 to 100% of the mice in the vitamin A groups. We conclude that the MESA allowed identification of ACD potency for known sensitizers at very low concentrations which do not produce ACD with other techniques. The importance of dose-response studies for avoiding the high-dose reduced-response region was also shown. Based on the observation that the vitamin A-augmented MESA was considerably more sensitive than with regular feed, a companion study (P.S. Thorne. C. Hawk, S.D. Kaliszewski, P.D. Guiney, Fundam. Appl. Tox. 17, 807-820, 1991) presents tests of the enhancements to the MESA developed in this work, using weak sensitizers and complex mixtures.
Thorne
P S
PS
Department of Preventive Medicine and Environmental Health, College of Medicine, University of Iowa, Iowa City 52242.
Hawk
C
C
Kaliszewski
S D
SD
Guiney
P D
PD
D000818:Animals; D003877:Dermatitis, Contact / Q000209:etiology*; D004137:Dinitrochlorobenzene / Q000633:toxicity; D004139:Dinitrofluorobenzene / Q000633:toxicity; D004431:Ear, External; D004487:Edema / Q000139:chemically induced / Q000473:pathology; D006986:Hypervitaminosis A / Q000503:physiopathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C
D004137:Dinitrochlorobenzene; D004139:Dinitrofluorobenzene